News room
Videos & Podcasts
Videos
Digital Knowledge Series
Videos
Digital Knowledge Series
Videos
Digital Knowledge Series
Videos
Digital Knowledge Series
Podcasts
Videos
Videos
Videos
Videos
Press Releases
OPPI Annual Summit 2023
OTC Health & Wellness Conference
Anil Matai appointed as the new Director General of OPPI
Innovate India Conference
OPPI launches ‘Bharat Ke Liye’- a campaign to reinforce its commitment to improving health outcomes in India
OPPI launches ‘Bharat ke Liye’- a brand campaign to reinforce the commitment to improving health outcomes in India
OPPI elects Suresh Pattathil as New President
Vivek Sehgal appointed the new Director General of OPPI
Press Release OPPI Annual Summit 2022
OPPI felicitates innovative start-ups in the Healthcare Industry through the OPPI Excellence in Innovation Healthcare Start-up of the Year 2021 Award
Press Release - OPPI-QCI Quality Award for Excellent Facility of the year 2021
OPPI-Joint Statement - No one is Safe Until Everyone is Safe
IP Waiver Statement
Asawari Sathaye joins OPPI as Director, Communications & Patient Advocacy, March 1, 2021
S. Sridhar takes over as President, OPPI
OPPI Annual Summit 17th & 18th December 2020
Curtain Raiser - OPPI Annual Summit 2020
Press Release-OPPI members are committed to addressing COVID 19 situation in India
Sharad Tyagi appointed as President of OPPI
K G Ananthakrishnan appointed new Director General of OPPI
Press Release- Health Dialogue 2019
The Future of Supply Chain Management, 12th July 2019
Press Release- OPPI President Result Announcement
Press release OPPI's Fifth Healthcare Access Summit
Press Release Implementing Policies into Best Practices in NCD management
OPPI 50th AGM Press Release October 21, 2016
Press Release OPPI Election of Office Bearers 2016
Kanchana TK appointed new Director General of OPPI, May 31, 2016
Press Release OPPI Golden Jubilee Oct 17 2015
Fourth Access Summit August 7 2015
Final Press release OPPI AGM Sept 14
OPPI Statement on NPPA Notifications
OPPI HR Summit Press Release 10 Sept 14
Press release OPPI Healthcare Access Summit 08 Aug
Media
B2Bchief I MNC pharma body OPPI appoints Anil Matai as new director general
Bio Voice I OPPI appoints Anil Matai as Director-General
Biospectrum I OPPI appoints Anil Matai as Director-General
BW Healthcare World I Pharma Body OPPI Appoints Anil Matai As Director-General
ET health World I OPPI appoints Anil Matai as Director-General
ET I MNC pharma body OPPI appoints Anil Matai as new director general
Express Pharma I Anil Matai appointed Director-General of OPPI
FE Healthcare - OPPI appoints Anil Matai as Director-General
IBC24 I ओपीपीआई ने अनिल मताई को महानिदेशक नियुक्त किया
Latestly I OPPI Appoints Anil Matai as Director-General
Newsdrum I OPPI Appoints Anil Matai as Director-General
Bio Spectrum - Suresh Pattathil Quote (1st Sep 2023)
Bio Spectrum - Manoj Saxena I Quote
Express Pharma - Proposed new drug law may still have flaws
TOI-GST waiver may have limited benefit for patients MNCs ask
Business Standard - Print Edition - Waiver for rare diseases brings little relief
BW Heatlcare world - Extend GST Waiver To All Rare Diseases Drugs
Business Standard - Waiver for rare disease drugs brings little relief_ Pharma sector
Business Today - IGST exemption for some rare disease drugs Here is what it means for patients
HBL - Drugmakers step on it to meet August 1 deadline to sport bar/ QR codes
Changing paradigm of healthcare communications in India
Bio Spectrum - OPPI reinforces commitment to improving health outcomes in India
Pharmabiz - OPPI launches Bharat Ke Liye initiative reinforcing commitment to improving health outcomes in India
BioVoice - OPPI launches Bharat Ke Liye, reinforces commitment to improving health outcomes
India Pharma Post - OPPI launches Bharat Ke Liye to reinforce commitment to improve health outcomes
TOI - Counterfeit drugs - A major public health threat
TOI - Achieving the healthcare-for-all dream
ET Health World - Vivek Sehgal views innovation & R&D to propel the growth of Indian pharma Inc
LinkedIn Post - ET Health World - Vivek Sehgal
Money Control - Budget 2023 - Is uniform implementation of drug approval system a possibility in India
Business Today - Union Budget 2023-FM Nirmala Sitharaman makes big ticket announcements for pharma sector
Live Mint - Budget 2023 Reactions - ftcash CEO says Budget laid much-needed importance on MSME sector
Business Today - Budget 2023 - Healthcare for all should be the govts mantra
Business Today - Budget 2023 Pharma, healthcare industry seeks eased regulations, R&D-based incentives
ET Health World - Lifescience Budget Expectation 2023-24
ET Heath World - Union Budget 2023-24 - Pharma sector bullish on higher investments in R&D
NDTV - Budget 2023 - Centre Must Promote Research, Give Incentives To Boost Investment- Pharma Sector
Hindustan Times- Rajasthan Edition
Pioneer Delhi - Budget Whistlist
PTI - Budget 2023 - Pharma, healthcare industry seek simplified regulations, research-based incentives
Business Standard - Budget 2023 - Pharma, healthcare industries seek simplified regulations
Economic Times - Budget 2023 - Pharma, healthcare industry seek simplified regulations, research-based incentives
Money Control - Foreign pharma firms push for fast-tracking of new drug approvals, ease of doing business
Express Pharma - Budget 2023 - What industries look forward to
Biospectrum - Brought much optimism to the healthcare and pharma sector - OPPI
ET Health World - Union Budget 2023-24 Pharma industry hails move to promote research & innovation
Express Pharma - Union Budget 2023 - Industry lauds focus on R&D
Financial Express - Budget 2023 No major announcements on health front Allocations increase by meagre 12 per cent
Money Control - Pharma industry hails budgets positive thrust on research innovation
MSN - Union Budget 2023 FM Nirmala Sitharaman makes big ticket announcements for pharma sector
Pharmabiz - Health industry associations hail Union Budget 2023 with emphasis on innovation
Anti-microbial resistance: Public-private collaboration and policy reforms can amplify R&D efforts
PharmaBiz - Need to create a robust regulatory framework for OTC medicines KG Ananthakrishnan
S Sridhar’s Email Interaction- BioSpectrum India, May 2021 edition
Adgully - How digital technology is proving to be a game-changer in healthcare
The Hindu Business Line - Pay for medicines as per your income
The Hindu Business Line - Pharmaceutical producers’ body bats for IPAB
ET Healthworld - Drug Price Control A Double Edged Sword
The Print - India ‘pharmacy to world’ but sector is fragmented, unorganised
Express Pharma - Pharma sector reacts to Union Budget 2021
CNBC TV18 - COVID-19 Indian healthcare comes of age
BioSpectrum - Industry opens bag of expectations for Union Budget 2021-22